Ovitrelle
Powder and solvent for solution for injection
Compare
|
EU/1/00/165/004
Authorised: 07/02/2001
Merck Europe B.V.
|
SPC
PIL
IPAR
|
Ovitrelle
Powder and solvent for solution for injection
Compare
|
EU/1/00/165/005
Authorised: 07/02/2001
Merck Europe B.V.
|
SPC
PIL
IPAR
|
Ovitrelle
Powder and solvent for solution for injection
Compare
|
EU/1/00/165/006
Authorised: 07/02/2001
Merck Europe B.V.
|
SPC
PIL
IPAR
|
Ovitrelle
Solution for injection in pre-filled syringe
Compare
|
EU/1/00/165/007
Authorised: 24/10/2003
Ares-Serono (Europe) Limited
|
SPC
PIL
IPAR
|
Ovitrelle
Solution for injection in pre-filled syringe
Compare
|
EU/1/00/165/008
Authorised: 23/06/2011
Merck Europe B.V.
|
SPC
PIL
IPAR
|
Ovranette 150 micrograms/30 micrograms coated tablets
Coated tablet
Compare
|
PA0822/094/001
Authorised: 01/04/1984
Pfizer Healthcare Ireland
|
SPC
PIL
|
Ovreena 30 micrograms/150 micrograms coated tablets
Coated tablet
Compare
|
PA1330/015/001
Authorised: 20/01/2006
Gedeon Richter Plc
|
SPC
PIL
|
Oxaliplatin 5 mg/ml concentrate for solution for infusion
Concentrate for solution for infusion
Compare
|
PA2059/049/001
Authorised: 24/07/2009
Fresenius Kabi Deutschland GmbH
|
SPC
PIL
|
Oxaliplatin 5mg/ml Concentrate for Solution for Infusion
Concentrate for solution for infusion
Compare
|
PA2315/114/001
Authorised: 19/03/2010
Accord Healthcare Ireland Ltd.
|
SPC
PIL
|
Oxaliplatin medac 5 mg/ml powder for solution for infusion
Powder for solution for infusion
Compare
|
PA0623/008/001
Authorised: 23/02/2007
medac Gesellschaft für klinische Spezialpräparate mbH
|
SPC
PIL
|
Oxbryta
Film-coated tablet
Compare
|
EU/1/21/1622/001
Authorised: 14/02/2022
Pfizer Europe MA EEIG
|
SPC
PIL
IPAR
|
Oxervate
Eye drops, solution
Compare
|
EU/1/17/1197/01
Authorised: 06/07/2017
Dompe farmaceutici SpA
|
SPC
PIL
IPAR
|
Oxis Turbohaler 12, inhalation powder
Inhalation powder
Compare
|
PA1019/015/002
Authorised: 10/03/2002
AstraZeneca AB
|
SPC
PIL
|
Oxis Turbohaler 6, inhalation powder
Inhalation powder
Compare
|
PA1019/015/001
Authorised: 10/03/2002
AstraZeneca AB
|
SPC
PIL
|
Oxlumo
Solution for injection
Compare
|
EU/1/20/1496/001
Authorised: 19/11/2020
Alnylam Netherlands B.V.
|
SPC
PIL
IPAR
|
Oxybuprocaine Agepha 4 mg/ml eye drops, solution
Eye drops, solution
Compare
|
PA22584/002/001
Authorised: 27/01/2023
AGEPHA Pharma s.r.o.
|
SPC
PIL
|
Oxybutynin hydrochloride 2.5 mg tablets
Tablet
Compare
|
PA2315/038/001
Authorised: 25/05/2012
Accord Healthcare Ireland Ltd.
|
SPC
PIL
|
Oxybutynin hydrochloride 2.5 mg/5 ml oral solution
Oral solution
Compare
|
PA22697/014/001
Authorised: 27/03/2015
Syri Pharma Limited t/a Thame Laboratories
|
SPC
PIL
IPAR
|
Oxybutynin hydrochloride 5 mg/5 ml oral solution
Oral solution
Compare
|
PA22697/014/002
Authorised: 27/03/2015
Syri Pharma Limited t/a Thame Laboratories
|
SPC
PIL
IPAR
|
Oxybutynin Hydrochloride 5mg Tablets
Tablet
Compare
|
PA2315/038/002
Authorised: 25/05/2012
Accord Healthcare Ireland Ltd.
|
SPC
PIL
|